Abstract. Ophiopogonin B (OP-B), a saponin compound isolated from Radix Ophiopogon japonicus, was verified to inhibit cell proliferation in numerous non-small cell lung cancer (NSCLC) cells in our previous study. However, the precise mechanisms of action have remained unclear. In the present study, we mainly investigated the effects of OP-B on adenocarcinoma A549 cells to further elaborate the underlying mechanisms of OP-B in different NSCLC cell lines. Detection by high content screening (HCS) and TUNEL assay verified that OP-B induced apoptosis in this cell line, while detection of Caspase-3, Bcl-2 and Bax showed that OP-B induced cell death was caspase and mitochondrial independent. Further experiments showed that OP-B induced cell cycle arrest in the S and G2/M phases by inhibiting the expression of Myt1 and phosphorylation of Histone H3 (Ser10), which resulted in mitotic catastrophe in the cells. Transmission electron microscopy (TEM) observation of cell micro-morphology combined with detection of Atgs by western blot analysis showed that OP-B induced autophagy in this cell line. Autophagy inhibition by the lysosome inhibitor CQ or Beclin1-siRNA knockdown both attenuated cell viability, demonstrated that autophagy also being the vital reason resulted in cell death. More importantly, the xenograft model using A549 cells provided further evidence of the inhibition of OP-B on tumor proliferation. Immunohistochemistry detection of LC3 and TUNEL assay both verified that high dose of OP-B (75 mg/kg) induced autophagy and apoptosis in vivo, and western blot detection of p-Histone H3 (Ser10), Survivin and XIAP further indicated the molecular mechanism of OP-B in vivo. As our findings revealed, multiple types of cell death overlapped in OP-B treated A549 cells, it displayed multitarget characteristics of the compounds extracted from the Chinese herbal, which may be used as candidate anticancer medicine in clinic.
Introduction
Lung cancer is one of the leading causes of cancer-related deaths in the world. Non-small cell lung cancer (NSCLC) accounts for nearly 85% in all lung cancer cases, with adenocarcinoma, squamous cell carcinoma and large cell carcinoma being the main histological subtypes (1) . Current clinical treatments such as surgery, radiotherapy and chemotherapy are still insufficient for NSCLC-treatment (2, 3) and new therapeutics need to be developed.
Traditional Chinese Medicine is efficient in improving clinical symptoms, regulating tumor growth and preventing the recurrence of lung cancer in patients. In our previous study, we found that the "Ke Jinyan Priscription", given by the State Medical Master Zhou Zhongying, inhibited the proliferation of NCI-H157 or A549 transplanted tumors, respectively, in nude mice, and the physical status of the animals was significantly improved (4) . Some ingredients extracted from the formula showed significant inhibitory effects on NSCLC cell lines under screening on the high-throughput platform (5, 6) . In particular, one of the derived compounds, ophiopogonin B (OP-B), showed especially potent inhibition of a series of NSCLC cell lines, and in H157 and H460 cell lines it mainly induced autophagic cell death which was caspase-independent (7) .
Besides autophagy, the caspase-independent programmed cell death (PCD) includes paraptosis, mitotic catastrophe, and the descriptive model of apoptosis-like and necrosis-like PCD. Once caspase-mediated routes fail in vivo, caspase-independent cell death pathways are important for cleaning unwanted or harmful cells, which can also be triggered by cytotoxic agents or other death stimuli (8) . As potentially new cancer therapies could be developed, the growing knowledge of the caspase-independent cell death pathways is very important for oncology research (8 To establish whether OP-B triggered different types of caspase-independent cell death in NSCLC cell lines, herein, we tested its effects on human lung adenocarcinoma A549 cells. The results revealed that OP-B induced mitotic catastrophe in A549 cells in vitro, and the mechanism may due to the inhibition of Myt1 and p-Histone H3 (Ser10) and the specific regulation of the cell cycle, combined with induction of autophagy, it resulted in caspase-independent apoptosis in this cell line. Moreover, OP-B inhibited expression of XIAP, survivin and the phosphorylation of Histone H3 (Ser10), thereby induced autophagy and apoptosis in vivo. Compared with its effects on H157 and H460 cells, the investigation demonstrated that OP-B may be more efficient in treating A549 cells.
Materials and methods
Reagents. Ophiopogonin B (OP-B) (MW: 722.9, HPLC ≥98%) was purchased from Nanjing Zelang Medical Technology Co., Ltd. (Nanjing, China). The chemicals used were staurosporine, chloroquine (CQ), propidium iodide (PI), (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT), DAPI and Hoechst 33258 (Sigma-Aldrich, St. Louis, MO, USA). The Alexa Fluor 488 Annexin V/Dead Cell apoptosis kit (Invitrogen, Waltham, MA, USA) and the In Situ Cell Death Detection kit (Roche, Indianapolis, IN, USA) were also obtained commercially.
Cell culture and transient transfection.
The human NSCLC cell line (A549) was obtained from the Institute of Biochemistry and Cell Biology (Shanghai, China). The A549 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) and F12 medium (HyClone Laboratories, Logan, UT, USA), respectively, supplemented with 10% fetal bovine serum (FBS; Gibco, Waltham, MA, USA), 100 U/ml penicillin-streptomycin mixed antibiotics at 37˚C in a humidified 5% CO 2 incubator.
For transient transfection, A549 cells were seeded in 6-cm culture dishes at a density of 10 6 cells/dish and then transfected with rat Beclin1 siRNAs (C-300506-03-0005; Dharmacon, Lafayette, CO, USA) using Lipofectamine 2000 reagent (13778-075; Invitrogen) according to the manufacturer's protocol.
Transmission electron microscopy (TEM). After being exposed to 10 µM of OP-B for 48 h, the cells were trypsinized, washed with phosphate-buffered saline (PBS) and fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) overnight at 4˚C. The next day, cells were washed three times with 0.1 mol/l phosphate buffer. Thereafter, the cells were fixed in 1% aqueous osmium, dehydrated with increasing concentrations of ethanol (30, 50, 70, 80, 90 and 100%) and embedded in araldite. The ultrathin sections were prepared with a microtome (Leica Microsystems, Wetzlar, Germany) and mounted on copper grids. The samples were stained with 2% aqueous uranyl acetate and lead citrate and observed by TEM (JEOL, Ltd., Tokyo, Japan).
High-content screening (HCS).
Apoptosis and dead cells induced by OP-B were assayed using the KineticScan Reader (Thermo Fisher Scientific, Waltham, MA, USA). The principle of the assay is that cells are labeled with a cocktail of fluorescent dyes (including Hoechst 33258 and Alexa Fluor 488 Annexin V) that indicate the cellular properties of interest, including nuclear structure, cell membrane permeability, as well as early and late stages of apoptosis. All procedures were performed according to the manufacturer's instructions. The cells were plated at a density of 8x10 3 cells/ well in each well of a 96-well plate. After culturing for 24 h, cells were incubated with 10 µM OP-B for another 24 h. Thirty minutes before the completion of incubation, a cocktail of fluorescent dyes was added to each well. The cells were then fixed with pre-warmed fixation solution and washed twice with PBS. Plates were then sealed and processed on an HCS Reader to acquire images. Images were analyzed with HCS software, and fluorescence intensities of the Hoechst 33258 and Annexin V/PI dyes were calculated. As for DAPI staining, the cells were cultured and treated and detected by HCS as above.
Western blot analysis. After treatment with different concentrations of OP-B, the cells were lysed in RIPA buffer containing 50 mmol/l Tris-HCl (pH 8.0), 150 mmol/l NaCl, 1% Nonidet-P40, 1% sodium deoxycholate, 0.1% SDS, 0.1 mmol/l DTT, 0.05 mmol/l PMSF, 0.002 mg/ml aprotinin, 0.002 mg/ml leupeptin and 1 mmol/l NaVO 3 . The protein concentrations of supernatants were determined by the BCA protein assay. Equal amounts of protein were loaded and separated by 10 or 12% SDS-PAGE and then transferred onto polyvinylidene difluoride membranes. The membranes were incubated overnight with appropriate primary antibodies against LC3 I/II, Beclin-1, Atg3, Atg-5/12, p-Histone H3 (Ser10), caspase-3, Bcl-2, Bax, cyclin D1, cyclin D3, CDK4, CDK6, cyclin A2, CDK2, cyclin B1, Myt1, p-cdc2, p21, p27, survivin, XIAP or β-actin overnight at 4˚C, and then with HRP-conjugated secondary antibodies (anti-rabbit or mouse immunoglobulin G) for an additional hour at room temperature. Immunoreactivity was detected by enhanced chemiluminescence (ECL; Bio-Rad Laboratories, Hercules, CA, USA). β-actin was used as a loading control. Immunoblot experiments were performed at least three times. Image acquisition was performed using Image Lab™ software.
Immunohistochemistry assay. The immunohistochemistry for LC3 localization in the tumor was performed as previously described (9) .
Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay. TUNEL staining was performed by using the 'In Situ Cell Death Detection kit' from Roche following the manufacturer's instructions.
Cell cycle analysis and apoptosis detection. After cells were treated with or without OP-B for 24 h, they were harvested by centrifugation, washed with ice-cold PBS and fixed in ice-cold 70% ethanol overnight. The cells were then treated with 40 µg/ml RNase at 37˚C and stained with 40 µg/ml PI for 30 min. The percentage of cells in each phase (sub G1, G0/G1, S and G2/M) was calculated (Becton-Dickinson, Franklin Lakes, NJ, USA).
MTT assay. Cell viability was assessed by the MTT reduction assay as described by Mosmann (10) . Viability of non-treated cells was taken as 100% and IC 50 values were determined from three independent experiments.
Nude mouse xenografts. Five-week-old athymic BALB/c mice were maintained under specific pathogen-free conditions and manipulated according to protocols approved by the Shanghai Medical Experimental Animal Care Commission. Exponentially growing A549 cells (2x10 6 in 0.2 ml medium) were inoculated subcutaneously into the flank of the mice. After 7 days, tumor-bearing mice were randomly divided into three groups, which were treated with OP-B (15 or 75 mg/kg p.o. daily; n=6) or corn oil (control, 100 µl, p.o. daily; n=6) for 21 consecutive days. Tumor growth was determined by measuring the size of the tumors every 2 days. The mice were euthanized at day 21, and the tumors were isolated, photographed and embedded in paraffin or frozen at -80˚C for subsequent western blot detection of p-Histone H3 (Ser10), survivin and XIAP, immunohistochemical analysis of LC3 expression as well as for the TUNEL assay.
Statistical analysis. Unless otherwise stated, data are expressed as the mean ± standard deviation (SD) and analyzed by the Student's t-test. A P-value <0.05 was considered statistically significant. (Fig. 1A and B) .
Results

OP-B treatment induces caspase-independent apoptosis in
TUNEL staining assay is another effective method for marking clipped nucleic acids and nucleus-morphology observation of apoptotic cells. Compared with staurosporine (STS), a positive inducer of apoptosis which significantly induced cell chromatin condensation and TUNEL-detectable fragmentation, 10 µM of OP-B treatment resulted in DNA-fragmentation moderately in A549 cells (Fig. 1D) .
Further detection of apoptosis-related protein showed that OP-B-treatment did not induce activation of caspase-3 or change the levels of Bcl-2 and Bax (Fig. 1E) .
Taken together, OP-B induced DNA-fragmentation and cell death in A549 cells caspase-independently. The regulation of cell cycle transition is known to be governed by the concerted action of cyclin-dependent kinases (CDKs) and their regulatory cyclin subunits (11, 12) . Among them, cyclin A, cyclin E and CDK2 regulate normal S-phase progression, while cyclin B1 is involved in G2-phase progression. During progression into mitosis, the critical regulatory step is dephosphorylation of cdc2 at Tyr15 and Thr14, while phosphorylation of cdc2 by the protein kinases Wee1 and Myt1 results in inhibition of cdc2 (13) . Moreover, phosphorylation of Histone H3 (Ser10) can drive mitotic chromosomal condensation during M phase entry (14) .
OP-B causes
After treated with 0, 5 and 10 µM of OP-B, the correlated proteins in the cells was detected by western blot assay. The results showed that OP-B did not affect the expression of cyclin D, CDK4, CDK6, cyclin A2, CDK2 and cyclin B1, while significantly inhibited the expression of Myt1 and the phosphorylation of cdc2 (Tyr15) and Histone H3 (Ser10).
Whereas, detection of CDK inhibitors p21
Waf1/Cip1 and p27
Kip1
showed that OP-B markedly increased the level of p27
( Fig. 2B) . Cell cycle arrest in G2/M phase was apt to induce mitotic catastrophe which was characterized as large cells with multiple micronuclei and decondensed charomatin. After 24-h treatment with 10 µM of OP-B, A549 cells were stained with DAPI and detected by HCS, the results showed that OP-B induced formation of micronuclei in the nucleus (Fig. 2C) .
Thus, we speculated that inhibition of OP-B on Myt1 and p-Histone H3 (Ser10) and enhancement of p27
Kip1 induced cell cycle arrest in S and G2/M phase and resulted in mitotic catastrophe.
Autophagy is involved in cell death induced by OP-B in A549 cells.
We have reported that OP-B induced autophagy in H157 and H460 cells (7) . To investigate whether this type of cell death also occurs in OP-B treated A549 cells, we detected autophagy in this cell line. First, the micro-morphological change of OP-B treated A549 cells was observed by TEM. The results showed that OP-B treatment also resulted in numerous vacuoles in the cytoplasm (Fig. 3A) . Then, detection of microtubule-associated protein 1 light chain 3 (LC3), the specific marker of autophagy showed that 12 or 24 h of treatment with OP-B significantly increased the transition of LC3-I to LC3-II (Fig. 3B) . Atg proteins participate in the processes of autophagosome-formation (15) . Synchronism detection showed that OP-B also upregulated the expression of Atg3, Atg5-Atg12 in the cells (Fig. 1B) . Taken together, the results verified that OP-B also induced autophagy in A549 cells.
As is known, at the last phage of autophagy, lysosome fuses with autophagosome, then formats autophagolysosome. Chloroquine (CQ) is the inhibitor of lysosome which inhibits lysosomal degradation (16) . In order to determine the role of autophagy in OP-B-induced cell death in A549 cells, the effect of CQ on OP-B-induced cell viability was initially evaluated. As shown in Fig. 3C , the decreased cell viability that resulted from 24 h of exposure to OP-B was effectively rescued by pretreatment with CQ, suggesting that OP-B-mediated autophagy promotes cell death in A549 cells.
Importantly, genetic inhibition of OP-B-mediated autophagy by transfection with Beclin1 siRNA also significantly decreased the cell distribution in Sub G1 phase exerted by OP-B in A549 cells (Fig. 3D) . Together, the data indicated that OP-B-induced autophagy was the vital reason which resulted in apoptosis in A549 cells.
OP-B inhibits NSCLC xenograft growth in association with induced autophagy and apoptosis.
To further authenticate the effects of OP-B described above, animal experiments were designed to test whether OP-B could induce autophagic and apoptotic cell death in vivo, and NSCLC xenografts in nude mice were established using A549 cells. The results showed that the growth of NSCLC tumors was significantly inhibited by treatment with OP-B at 75 mg/kg compared with the vehicle controls ( Fig. 4A and B) . Results of western blot assay showed that the high dose of OP-B significantly inhibited the phosphorylation of Histone H3 (Ser10), and at both of the doses of OP-B the levels of survivin and XIAP were inhibited (Fig. 4C) . The tumors from OP-B-treated mice exhibited significantly increased expression of LC3; moreover, treatment with OP-B significantly induced cellular apoptosis in tumor tissues as evidenced by the TUNEL assay (Fig. 4D) . These results indicated that OP-B could induce autophagic and apoptotic cell death in A549 cells in vivo, which may be an important mechanism underlying the antitumor activities of OP-B.
Discussion
In our previous study, we reported that OP-B inhibited proliferation of a panel of NSCLC cell lines; importantly, it showed a relatively low IC 50 in A549 cells (2.63 µM) (7). As approximately 40% of lung cancers are adenocarcinomas in clinic, in the present study we focused on the effect of OP-B on A549 cells in vitro and in vivo to further elaborate the underlying mechanisms of OP-B in NSCLC.
Firstly, positive labeling of Annexin V/PI and TUNEL staining both demonstrated that OP-B caused apoptosis in A549 cells (Fig. 1A-C) , while detection of caspase-3, Bcl-2 and Bax showed that the apoptosis was caspase and mitochondrial independent (Fig. 1D) .
Cell cycle arrest is another key factor preventing tumor growth. In the previous study, we reported that OP-B induced cell cycle arrest in the G0/G1 phase in H157 and H460 cell lines (7) . However, our current flow cytometric analysis in A549 cells showed that OP-B markedly suppressed the cell mitotic progression through arresting cells in the S and G2/M phase; whereas, it dose-dependently induced the increase of cells in the Sub-G1 phase ( Fig. 2A) . It is well known that the eukaryotic cell cycle is regulated by the coordinated activity of CDK kinase complexes which form and are activated at specific cell cycle stage (17) . These cyclin-CDK complexes often bind to the endogenous inhibitor p21 WAF1/CIP1 or p27 KIP1 , which inhibits their kinase activities and prevent cell cycle progression. Detection of these proteins showed that OP-B upregulated p27 KIP1 , while downregulated Myt1, p-cdc2 and p-Histone H3 (Ser10) in A549 cells (Fig. 2B) . Phosphorylation at Ser10, Ser28 and Thr11 of Histone H3 is tightly correlated with chromosome condensation during both mitosis and (18) , and singular phosphorylation of Histone H3 (Ser10) can act as part of a molecular mechanism driving mitotic chromosomal condensation during M phase entry (14) . Further observation of the nucleus morphology by DAPI staining showed that OP-B treatment resulted in micronuclei formation in the cells, being the typical characteristic of mitotic catastrophe (Fig. 2C) . Taken together, upregulation of p27 KIP1 and suppression of p-Histone H3 (Ser10) resulted in cell cycle arrest in S and G2/M phase, and further induced mitotic catastrophe in A549 cells.
Autophagy has a complex relationship with apoptosis, especially in tumor cell lines (19) (20) (21) (22) . Here, cell micro- morphology observed by TEM combined with detection of autophagy-related proteins by western blotting showed that OP-B also induced autophagy in A549 cells (Fig. 3A and B) . Moreover, lysosome inhibitor CQ or Beclin1 siRNA knockdown were shown to both attenuate the level of cell apoptosis ( Fig. 3C and D) , indicating that autophagy promoted apoptosis in A549 cells. As known, not only caspases, other proteases can also execute programmed cell death, and they can be directed by several cellular organelles, including mitochondria, lysosomes, and the ER, which can collaborate with each other or act independently. Different death routes may overlap and several characteristics may be displayed at the same time (6, (23) (24) (25) .
For these multiple action of OP-B on A549 cells in vitro, we used 15 and 75 mg/kg of OP-B in A549 xenografts nude mice to detect its effect in vivo. The results showed that OP-B exerted significant inhibition of tumor proliferation (Fig. 4A  and B) . The mechanism may be related with phosphorylation inhibition of Histone H3 (Ser10) and suppression on survivin and XIAP (Fig. 4C) , which resulted in mitotic catastrophe and further induced autophagy and apoptosis (Fig. 4D) of the tumor cells.
Taken together, other than its action on H157 and H460 cells, OP-B exerted overlapped types of cell death in A549 cells, including mitotic catastrophe, autophagy and caspaseindependent apoptosis (Fig. 5) . The difference may due to the unique characteristics of different cell lines. As having the distinguishing trait of type II pulmonary epithelial cells, A549 cells usually form confluent monolayers during growth, and they express P450 IA1 and P450 IIB6 isozymes, which facilitate delivery of macromolecules and are important for metabolism of drugs (26) . This may be the reason for A549 cells to be more sensitive to OP-B. Thus, OP-B may be developed as an alternative agent that can be used for the classification and treatment of NSCLC.
